Rare diseases
Investigational molecules
Locations
Back to Bulgaria100 clinical trials in Burgas, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
BulgariaStudy of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis
BulgariaA study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia
BulgariaStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
BulgariaA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
BulgariaA study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines
BulgariaA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
BulgariaStudy of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration
BulgariaStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
BulgariaLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder
BulgariaStudy of trospium chloride and xanomeline tartrate (KarXT) for treatment of manic episodes in adults with bipolar I disorder
BulgariaStudy of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lung cancer and breast cancer treatments, including studies of novel therapies for metastatic conditions. Research encompasses both targeted and immunotherapy approaches.
Emphasis on developing treatments for patients with specific genetic markers and testing new combination therapies.
Comprehensive research into cardiovascular disease prevention and treatment, including innovative approaches to managing atherosclerosis and stroke prevention.
Multiple trials evaluating new compounds for lipid management and cardiovascular risk reduction.
Studies focused on chronic respiratory conditions including COPD and asthma, testing advanced inhalation therapies and novel treatment approaches.
Investigation of new therapeutic combinations and delivery systems for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
